NDC 0378-7010

Loxapine

Loxapine

Loxapine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Loxapine Succinate.

Product ID0378-7010_500e424b-5d74-4d48-80b7-2ea6c97fc91b
NDC0378-7010
Product TypeHuman Prescription Drug
Proprietary NameLoxapine
Generic NameLoxapine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2004-11-03
Marketing CategoryANDA / ANDA
Application NumberANDA076762
Labeler NameMylan Pharmaceuticals Inc.
Substance NameLOXAPINE SUCCINATE
Active Ingredient Strength10 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0378-7010-01

100 CAPSULE in 1 BOTTLE, PLASTIC (0378-7010-01)
Marketing Start Date2004-11-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0378-7010-01 [00378701001]

Loxapine CAPSULE
Marketing CategoryANDA
Application NumberANDA076762
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-11-03

NDC 0378-7010-05 [00378701005]

Loxapine CAPSULE
Marketing CategoryANDA
Application NumberANDA076762
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-11-03
Marketing End Date2016-12-02

Drug Details

Active Ingredients

IngredientStrength
LOXAPINE SUCCINATE10 mg/1

OpenFDA Data

SPL SET ID:1a03c19b-d44f-ae98-f404-022eb8392677
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311386
  • 314075
  • 311385
  • 314078